Company
RenovoRx, Inc. (RNXT)
Standardized SEC financial data for RenovoRx, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001574094 · NASDAQ · Pharmaceutical Preparations.
Gross margin
70.9%
Operating margin
-1000.0%
Net margin
-994.5%
Revenue growth (YoY)
2511.6%
Return on equity
-206.0%
Free cash flow
-$11.0M
Current ratio
4.02×
EPS (diluted)
$-0.32
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $43K | $1.1M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.8M | $15.2M | $6.4M | $1.2M | $7.2M | $7.0M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$3.5M | -$5.9M | -$8.8M | -$10.3M | -$9.1M | -$11.0M |
| Capital expenditures |
Get RNXT data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/RNXT/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/RNXT/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"